Literature DB >> 7474941

Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney.

C Heilig1, C Zaloga, M Lee, X Zhao, B Riser, F Brosius, P Cortes.   

Abstract

BACKGROUND: Facilitative glucose transporters (GLUT) have unique kinetic characteristics and distributions suited to the functions of the tissues in which they reside. However, little is known about their individual roles in renal glucose metabolism, and previous investigations of renal GLUT expression have been extensive only with respect to their mRNA levels. We provide here a complete analysis of three GLUT isoforms along the nephron using a sensitive immunodetection method. EXPERIMENTAL
DESIGN: Normal rat kidneys were harvested, fixed in paraformaldehyde, and embedded in either paraffin or resin as required for immunogold labeling of individual GLUT Isoforms 1, 3, and 4. Samples were evaluated by light microscopy and selected regions analyzed by high resolution optical scanning with computer-assisted detection of immunogold-labeled GLUT at the subcellular level. We describe, compare, and related to the local patterns of glucose metabolism the cellular and subcellular expression patterns of these GLUT along the nephron.
RESULTS: GLUT1 was most intensely labeled in the medullary thick ascending limbs of Henle, cortical collecting ducts, and inner medullary collecting ducts. In contrast, GLUT3 was most prominent in the inner medullary collecting ducts and GLUT4 in medullary thick ascending limbs of Henle. All three GLUT were detected in glomerular tufts, and GLUT1 was also detected in parietal epithelial cells. The predominant subcellular distributions in tubule cells were: basolateral and basolateral/cytoplasmic for GLUT1; basolateral and cytoplasmic for GLUT3; and perinuclear/cytoplasmic for GLUT4. GLUT 1 and 3 expressions were confirmed in specific regions by immunoblotting.
CONCLUSIONS: 1) GLUT 1, 3, and 4 are expressed in both glomeruli and renal tubules. 2) The unique GLUT expression patterns along the renal tubules suggests unique functional roles for these isoforms. 3) The renal cortex demonstrates lesser labeling intensity for the high-affinity GLUT compared with the medulla, where higher rates of glucose oxidation and glycolytic metabolism are paralleled by higher GLUT labeling intensities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474941

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton.

Authors:  R C Bunn; M A Jensen; B C Reed
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

2.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

3.  Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.

Authors:  Dilip K Deb; Riyue Bao; Yan Chun Li
Journal:  FASEB J       Date:  2017-02-01       Impact factor: 5.191

Review 4.  Glucose transporters in diabetic nephropathy.

Authors:  Frank C Brosius; Charles W Heilig
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

Review 5.  Associations between structural and functional changes to the kidney in diabetic humans and mice.

Authors:  David W Powell; David N Kenagy; Shirong Zheng; Susan C Coventry; Jianxiang Xu; Lu Cai; Edward C Carlson; Paul N Epstein
Journal:  Life Sci       Date:  2013-06-22       Impact factor: 5.037

Review 6.  Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.

Authors:  Wenpeng Cui; Bing Du; Wenhua Zhou; Ye Jia; Guangdong Sun; Jing Sun; Dongmei Zhang; Hang Yuan; Feng Xu; Xuehong Lu; Ping Luo; Lining Miao
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

7.  Mitochondrial and nuclear gene mutations in the type 2 diabetes patients of Coimbatore population.

Authors:  Viswanadha Vijaya Padma; Shobana Anitha; Elango Santhini; Duraisamy Pradeepa; Dominic Tresa; Perumal Ganesan; Periyasamy Ishwarya; Ramanathan Balamurugan; Ramanathan Balakrishnan
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

8.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

Review 9.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

10.  Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress.

Authors:  Charles Heilig; Frank Brosius; Brian Siu; Luis Concepcion; Richard Mortensen; Kathleen Heilig; Min Zhu; Richard Weldon; Guimei Wu; David Conner
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.